SAN CARLOS, Calif., September 15, 2014 -- CellProThera and BioCardia will collaborate on the EXCELLENT (Expanded Cell Endocardiac
Transplantation) Trial, a multicenter, controlled Phase l/2b study to evaluate the safety and efficacy of in vitro expanded peripheral blood CD34+ stem cells output by the StemXpand Automated Process and delivered via the BioCardia Helix Transendocardial Delivery System.
Duan, "Thermal modelling for endocardiac
radiofrequency ablation: comparison bioheat equation and Pennes bioheat equation with finite element method," 2012, http://arxiv.org/ftp/arxiv/papers/1204/1204.0098.pdf.
In our study, with vagal response and by endocardiac
mapping, we found that the potentials of LA and PV at LA, PV-LAJ, LSPVm and LSPVd were overlapped with sinus rhythm, were separated by pacing at each sites mentioned above, and were separated remarkably by stimulating at the distal part of LSPV.